ASPI

Company Overview — What Does ASP Isotopes Inc. Do?

We are a pre-commercial stage advanced materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries. We have an exclusive license to use proprietary technology, the Aerodynamic Separation Process (“ASP technology”), originally developed and licensed to us by Klydon Proprietary Ltd (“Klydon”), for the production, distribution, marketing and sale of all isotopes. Our initial focus is on the production and commercialization of enriched Molybdenum-100 (“Mo-100”). Klydon has agreed to provide us a first commercial-scale Mo-100 enrichment plant located in South Africa with a manufacturing capacity of 20 kg/year of 95% enriched Mo-100 when fully operational. We believe that the Mo-100 we may develop using the ASP technology has significant potential advantages for use in the preparation of nuclear imaging agents by radiopharmacies and others in the medical industry. We also intend to use the ASP technology licensed to us by Klydon to produce enriched Uranium-235 (“U-235”). We believe that the U-235 we may develop using the ASP technology may be commercialized as a nuclear fuel component for use in the new generation of HALEU-fueled small modular reactors that are now under development for commercial and government uses. We may also seek to use the ASP technology to separate Silicon-28, which we believe has potential application in the quantum computing target end market, and Carbon-14, which we believe has potential application in the pharma/agrochem target end market. In addition, we are considering future development of the ASP technology for the separation of Zinc-68, Ytterbium-176, Zinc-67, Nickel-64 and Xenon-136 for potential use in the healthcare target end market, and Chlorine -37 and Lithium-6 for potential use in the nuclear energy target end market. We operate principally through subsidiaries: ASP Isotopes Guernsey Limited (the holding company of ASP Isotopes South Africa (Proprietary) Limited), which will be focused on the development and commercialization of high value, low volume isotopes for highly specialized end markets (such as Mo-100 and others, including Silicon-28); Enriched Energy LLC, which will be focused on the development and commercialization of uranium for the nuclear energy market; and ASP Isotopes UK Ltd, which is the licensee of the ASP technology under the exclusive license agreement with Klydon. We were incorporated in Delaware in September 2021. Our principal executive offices are located at 433 Plaza Real, Suite 275, Boca Raton, Florida. ASP Isotopes Inc. (ASPI) is classified as a small-cap stock in the Materials sector, specifically within the Chemicals industry. The company is led by CEO Paul E. Mann. With a market capitalization of $514M, ASPI is one of the notable companies in the Materials sector.

ASP Isotopes Inc. (ASPI) Stock Rating — Avoid (April 2026)

As of April 2026, ASP Isotopes Inc. receives a Avoid rating with a composite score of 26.1/100 and 1 out of 5 stars from the Blank Capital Research quantitative model.ASPI ranks #4,104 out of 4,446 stocks in our coverage universe. Within the Materials sector, ASP Isotopes Inc. ranks #280 of 284 stocks, placing it in the lower half of its Materials peers. The rating is generated by a multi-factor model that weighs quality (30%), momentum (25%), value (15%), investment (10%), stability (10%), and short interest (10%).

ASPI Stock Price and 52-Week Range

ASP Isotopes Inc. (ASPI) currently trades at $4.40. The stock gained $0.19 (4.5%) in the most recent trading session. The 52-week high for ASPI is $14.49, which means the stock is currently trading -69.6% from its annual peak. The 52-week low is $3.92, putting the stock 12.2% above its annual trough. Recent trading volume was 4.1M shares, reflecting moderate market activity.

Is ASPI Overvalued or Undervalued? — Valuation Analysis

ASP Isotopes Inc. (ASPI) carries a value factor score of 31/100 in the Blank Capital model, signaling premium valuation that prices in significant future growth. The price-to-book ratio stands at 5.27x, versus the sector average of 2.83x. The price-to-sales ratio is 61.52x, compared to 0.74x for the average Materials stock.

At current multiples, ASP Isotopes Inc. trades at a premium to most Materials peers. This elevated valuation may be justified if the company can sustain above-average growth rates and profitability, but it also creates downside risk if earnings disappoint expectations.

ASP Isotopes Inc. Profitability — ROE, Margins, and Quality Score

ASP Isotopes Inc. (ASPI) earns a quality factor score of 20/100, signaling below-average profitability metrics relative to the broader market. The return on equity (ROE) is -107.5%, compared to the Materials sector average of 3.3%, which is below typical expectations for high-quality companies. Return on assets (ROA) comes in at -46.0% versus the sector average of 0.6%.

On a margin basis, ASP Isotopes Inc. reports gross margins of 28.3%, compared to 29.8% for the sector. The operating margin is -631.6% (sector: 6.0%). Net profit margin stands at -1994.9%, versus 3.0% for the average Materials stock. Revenue growth is running at 378.3% on a trailing basis, compared to 1.8% for the sector. Profitability is below benchmark levels, which may reflect industry headwinds, elevated reinvestment, or structural challenges.

ASPI Debt, Balance Sheet, and Financial Health

ASP Isotopes Inc. has a debt-to-equity ratio of 14.0%, compared to the Materials sector average of 41.0%. The low leverage indicates a conservative balance sheet with significant financial flexibility. The current ratio is 6.14x, indicating strong short-term liquidity. Total debt on the balance sheet is $14M. Cash and equivalents stand at $114M.

ASPI has a beta of 1.77, meaning it is more volatile than the broader market — a $10,000 investment in ASPI would be expected to move 77.1% more than the S&P 500 on any given day. The stability factor score for ASP Isotopes Inc. is 17/100, suggesting elevated price swings that may be unsuitable for conservative portfolios.

ASP Isotopes Inc. Revenue and Earnings History — Quarterly Trend

In TTM 2026, ASP Isotopes Inc. reported revenue of $8M and earnings per share (EPS) of $-0.15. Net income for the quarter was $-104M. Gross margin was 28.3%. Operating income came in at $-40M.

In Q3 2025, ASP Isotopes Inc. reported revenue of $5M and earnings per share (EPS) of $-0.15. Net income for the quarter was $-13M. Gross margin was 8.6%. Revenue grew 349.5% year-over-year compared to Q3 2024. Operating income came in at $-15M.

In Q2 2025, ASP Isotopes Inc. reported revenue of $1M and earnings per share (EPS) of $-1.03. Net income for the quarter was $-75M. Gross margin was 47.7%. Revenue grew 17.2% year-over-year compared to Q2 2024. Operating income came in at $-12M.

In Q1 2025, ASP Isotopes Inc. reported revenue of $1M and earnings per share (EPS) of $-0.12. Net income for the quarter was $-8M. Gross margin was 29.7%. Revenue grew 31.1% year-over-year compared to Q1 2024. Operating income came in at $-8M.

Over the past 8 quarters, ASP Isotopes Inc. has demonstrated a growth trajectory, with revenue expanding from $840,354 to $8M. Investors analyzing ASPI stock should weigh these quarterly trends alongside the valuation and quality metrics discussed above.

ASPI Dividend Yield and Income Analysis

ASP Isotopes Inc. (ASPI) does not currently pay a dividend. This is common among smaller companies in the Chemicals industry that prefer to reinvest cash flows into business expansion rather than returning capital to shareholders. Income-focused investors looking for Materials dividend stocks may want to explore other Materials stocks or use the stock screener to filter by dividend yield.

ASPI Momentum and Technical Analysis Profile

ASP Isotopes Inc. (ASPI) has a momentum factor score of 30/100, signaling weak relative price performance. Stocks with low momentum scores have historically tended to continue underperforming in the near term. The investment factor score is 21/100, which measures capital allocation efficiency and asset growth patterns. The short interest score of 43/100 reflects moderate short selling activity.

ASPI vs Competitors — Materials Sector Ranking and Peer Comparison

Within the Materials sector, ASP Isotopes Inc. (ASPI) ranks #280 out of 284 stocks based on the Blank Capital composite score. This places ASPI in the lower half of all Materials stocks in our coverage universe. Key competitors and sector peers include CF Industries Holdings, Inc. (CF) with a score of 56.6/100, Nutrien Ltd. (NTR) with a score of 56.6/100, CVR PARTNERS, LP (UAN) with a score of 55.6/100, LSB INDUSTRIES, INC. (LXU) with a score of 53.6/100, and ACME UNITED CORP (ACU) with a score of 51.2/100.

Comparing ASPI against the S&P 500 benchmark is also instructive for understanding relative performance. Investors can view the full ASPI vs S&P 500 (SPY) comparison to assess how ASP Isotopes Inc. stacks up against the broader market across all factor dimensions.

ASPI Next Earnings Date

No upcoming earnings date has been announced for ASP Isotopes Inc. (ASPI) at this time. Check the earnings calendar for the latest scheduling updates across all stocks in our coverage universe.

Should You Buy ASPI? — Investment Thesis Summary

The quantitative profile for ASP Isotopes Inc. suggests caution. The quality score of 20/100 flags below-average profitability. The value score of 31/100 indicates premium valuation. Momentum is weak at 30/100, a headwind for near-term performance. High volatility (stability score 17/100) increases portfolio risk.

In summary, ASP Isotopes Inc. (ASPI) earns a Avoid rating with a composite score of 26.1/100 as of April 2026. The rating is derived from the Blank Capital Research methodology, which combines six factor dimensions into a single quantitative ranking. Investors should consider these quantitative signals alongside their own fundamental research, risk tolerance, and investment time horizon before making buy or sell decisions on ASPI stock.

Related Resources for ASPI Investors

Explore more research and tools: ASPI vs S&P 500 comparison, top Materials stocks, stock screener, our methodology, quality factor explained, value factor explained, momentum factor explained. Compare ASPI head-to-head with peers: ASPI vs CF, ASPI vs NTR, ASPI vs UAN.